281 related articles for article (PubMed ID: 23615820)
21. Evaluation of ODE-Bn-PMEG, an acyclic nucleoside phosphonate prodrug, as an antiviral against productive HPV infection in 3D organotypic epithelial cultures.
Banerjee NS; Wang HK; Beadle JR; Hostetler KY; Chow LT
Antiviral Res; 2018 Feb; 150():164-173. PubMed ID: 29287913
[No Abstract] [Full Text] [Related]
22. Gene- and protein-delivered zinc finger-staphylococcal nuclease hybrid for inhibition of DNA replication of human papillomavirus.
Mino T; Mori T; Aoyama Y; Sera T
PLoS One; 2013; 8(2):e56633. PubMed ID: 23437192
[TBL] [Abstract][Full Text] [Related]
23. Modulation of the DNA damage response during the life cycle of human papillomaviruses.
Anacker DC; Moody CA
Virus Res; 2017 Mar; 231():41-49. PubMed ID: 27836727
[TBL] [Abstract][Full Text] [Related]
24. Human TATA binding protein inhibits human papillomavirus type 11 DNA replication by antagonizing E1-E2 protein complex formation on the viral origin of replication.
Hartley KA; Alexander KA
J Virol; 2002 May; 76(10):5014-23. PubMed ID: 11967317
[TBL] [Abstract][Full Text] [Related]
25. The transcription map of HPV11 in U2OS cells adequately reflects the initial and stable replication phases of the viral genome.
Isok-Paas H; Männik A; Ustav E; Ustav M
Virol J; 2015 Apr; 12():59. PubMed ID: 25890000
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of two commercial preparations of interferon-alpha on human papillomavirus replication.
Sen E; McLaughlin-Drubin M; Meyers C
Anticancer Res; 2005; 25(2A):1091-100. PubMed ID: 15868951
[TBL] [Abstract][Full Text] [Related]
27. Identification of peptides that inhibit the DNA binding, trans-activator, and DNA replication functions of the human papillomavirus type 11 E2 protein.
Deng SJ; Pearce KH; Dixon EP; Hartley KA; Stanley TB; Lobe DC; Garvey EP; Kost TA; Petty RL; Rocque WJ; Alexander KA; Underwood MR
J Virol; 2004 Mar; 78(5):2637-41. PubMed ID: 14963172
[TBL] [Abstract][Full Text] [Related]
28. The Deacetylase SIRT1 Regulates the Replication Properties of Human Papillomavirus 16 E1 and E2.
Das D; Smith N; Wang X; Morgan IM
J Virol; 2017 May; 91(10):. PubMed ID: 28275188
[TBL] [Abstract][Full Text] [Related]
29. Identification of a 450-bp region of human papillomavirus type 1 that promotes episomal replication in Saccharomyces cerevisiae.
Chattopadhyay A; Schmidt MC; Khan SA
Virology; 2005 Sep; 340(1):133-42. PubMed ID: 16026811
[TBL] [Abstract][Full Text] [Related]
30. The molecular biology and HPV drug responsiveness of cynomolgus macaque papillomaviruses support their use in the development of a relevant in vivo model for antiviral drug testing.
Tombak EM; Männik A; Burk RD; Le Grand R; Ustav E; Ustav M
PLoS One; 2019; 14(1):e0211235. PubMed ID: 30682126
[TBL] [Abstract][Full Text] [Related]
31. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review.
Graham SV
Clin Sci (Lond); 2017 Sep; 131(17):2201-2221. PubMed ID: 28798073
[TBL] [Abstract][Full Text] [Related]
32. Acetylation of E2 by P300 Mediates Topoisomerase Entry at the Papillomavirus Replicon.
Thomas Y; Androphy EJ
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651357
[TBL] [Abstract][Full Text] [Related]
33. The role of the E1 and E2 proteins in the replication of human papillomavirus type 31b.
Frattini MG; Laimins LA
Virology; 1994 Nov; 204(2):799-804. PubMed ID: 7941349
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus E1 and E2 mediated DNA replication is not arrested by DNA damage signalling.
King LE; Fisk JC; Dornan ES; Donaldson MM; Melendy T; Morgan IM
Virology; 2010 Oct; 406(1):95-102. PubMed ID: 20673941
[TBL] [Abstract][Full Text] [Related]
35. Human Papillomavirus and the DNA Damage Response: Exploiting Host Repair Pathways for Viral Replication.
Spriggs CC; Laimins LA
Viruses; 2017 Aug; 9(8):. PubMed ID: 28820495
[TBL] [Abstract][Full Text] [Related]
36. A new mode of treatment of human papilloma virus associated anogenital lesions using a nonsteroid estrogen analogue.
Schön HJ; Grgurin M; Szekeres T; Schurz B
Wien Klin Wochenschr; 1996; 108(2):45-7. PubMed ID: 8835432
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and Antiviral Evaluation of Octadecyloxyethyl Benzyl 9-[(2-Phosphonomethoxy)ethyl]guanine (ODE-Bn-PMEG), a Potent Inhibitor of Transient HPV DNA Amplification.
Beadle JR; Valiaeva N; Yang G; Yu JH; Broker TR; Aldern KA; Harden EA; Keith KA; Prichard MN; Hartman T; Buckheit RW; Chow LT; Hostetler KY
J Med Chem; 2016 Dec; 59(23):10470-10478. PubMed ID: 27933957
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms by which HPV Induces a Replication Competent Environment in Differentiating Keratinocytes.
Moody C
Viruses; 2017 Sep; 9(9):. PubMed ID: 28925973
[TBL] [Abstract][Full Text] [Related]
39. Regulation of human papillomavirus type 16 DNA replication by E2, glucocorticoid hormone and epidermal growth factor.
Piccini A; Storey A; Romanos M; Banks L
J Gen Virol; 1997 Aug; 78 ( Pt 8)():1963-70. PubMed ID: 9266995
[TBL] [Abstract][Full Text] [Related]
40. Human Papillomavirus Replication Regulation by Acetylation of a Conserved Lysine in the E2 Protein.
Thomas Y; Androphy EJ
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
